Study of Biological Determinants of Bleeding Postpartum
NCT02884804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3599
Last updated 2016-08-31
Summary
At the entry of the delivery room, a standard blood analysis will be performed (Blood count, PT, aPTT, Fibrinogen, and D-Dimer) for each women (if they are agree), according to the center's practices.
The percentage of the immature platelets is a an additional parameter on the hemogram.
The clinical assessments (recorded in medical records) and biological values will be used to determine if there is a correlation between these data and the occurrence of postpartum hemorrhage.
Conditions
- Postpartum Hemorrhage
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Principal Investigators
-
PAN-PETESCH Brigitte, Dr. · CHRU de BREST
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2015-05-31
- Completion
- 2015-05-31
Countries
- France
Study Locations
More Related Trials
-
Ambulatory Blood Pressure and the Normal Increase in Maternal Blood Pressure Postpartum
NCT02912403 ·Status: WITHDRAWN
-
Left Rule, D-Dimer Measurement and Complete Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy.
NCT01708239 ·Status: UNKNOWN
-
Evaluation of a Patient Blood Management Protocol Impact on the Transfusion Rate in Delivery Hemorrhage
NCT06916832 ·Status: COMPLETED
-
Maternal-fetal Outcomes of Genital Blood Loss Beyond 18 Weeks of Pregnancy
NCT06802874 ·Status: RECRUITING
-
Early Placental Insufficiency Screening
NCT01348711 ·Status: TERMINATED
-
Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire
NCT05191251 ·Status: COMPLETED
-
Autophagy/Apoptosis Balance in Placental Vascular Pathologies
NCT06779916 ·Status: RECRUITING
-
Predictive Value of SFlt-1/PlGF Ratio for the Diagnosis of Cardiovascular Disorders in the Puerperium: Pilot Study
NCT06720857 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications
NCT00485784 ·Status: COMPLETED ·Phase: NA
-
Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage
NCT02149472 ·Status: COMPLETED
-
Improving Management of Post-partum Haemorrhage With Quantra® System
NCT05336838 ·Status: UNKNOWN
-
Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.
NCT03250884 ·Status: COMPLETED
-
Study of Coagulation Activation Markers and Pre Eclampsia
NCT01261351 ·Status: COMPLETED
-
GROSS-HIST : Quantification of the Main Circulating Histones During Normal Pregnancy and Pregnancies With Placenta-mediated Complications
NCT04205383 ·Status: COMPLETED
-
Doppler and Biological Second Trimester Placental Insufficiency Screening
NCT00465634 ·Status: COMPLETED
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING
-
Severe Post Partum Haemorrhage (PPH): A Randomized Trial on Transversal Intervention in 6 French Perinatal Networks
NCT00344929 ·Status: UNKNOWN
-
Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia
NCT03149250 ·Status: UNKNOWN
-
New Biomarkers Associated With the Risk of Premature Delivery.
NCT04067908 ·Status: COMPLETED ·Phase: NA
-
Bedside Assessment of Coagulation in Post-partum Hemorrhage by Thromboelastography (TEG ®6S)
NCT03592303 ·Status: UNKNOWN
-
Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.
NCT03455387 ·Status: COMPLETED
-
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
NCT02507180 ·Status: UNKNOWN
-
Twin Pregnancy Cohort
NCT05144321 ·Status: ACTIVE_NOT_RECRUITING
-
Thromboelastogram in Postdelivery Preeclamptic Patients
NCT03555630 ·Status: COMPLETED
-
Uterine Artery Pulsatility Index and Materno Fetal Outcomes
NCT02853058 ·Status: UNKNOWN ·Phase: NA